May 6, 2008
Genmab to Attend Two May Investor Conferences

Apr 30, 2008
Genmab’s Total Number of Voting Rights and Total Share Capital

Apr 28, 2008
Major Shareholder Announcement

Apr 24, 2008
Report Pursuant to Section 28a of the Danish Securities Trading Act

Apr 24, 2008
Constitution of the Board of Directors in Genmab and Grant of Warrants to Employees and a Member of Management

Apr 23, 2008
Passing of Genmab A/S' Annual General Meeting

Apr 15, 2008
Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS

Apr 7, 2008
Genmab A/S Summons Annual General Meeting

Apr 7, 2008
Major Shareholder Announcement

Apr 1, 2008
Capital Increase in Genmab as a Result of Employee Warrant Exercise

Mar 31, 2008
Genmab Announces Year End 2007 Financial Results

Mar 13, 2008
Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility

Mar 3, 2008
Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets

Feb 27, 2008
Genmab to Attend Two March Investor Conferences

Feb 26, 2008
Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance

Feb 21, 2008
Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility

Feb 5, 2008
Major Shareholder Announcement

Feb 4, 2008
Major Shareholder Announcement

Jan 31, 2008
Genmab’s Financial Calendar for 2008

Jan 30, 2008
Major Shareholder Announcement

Jan 29, 2008
Genmab to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

Jan 21, 2008
Genmab Reaches Milestones in Ofatumumab Collaboration

Jan 4, 2008
Genmab Announces HuMax-CD32b Pre-Clinical Program

Jan 3, 2008
Genmab to Present at the 26th Annual JPMorgan Healthcare Conference